Jinhua Huang

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

Hai‐Dong Zhu, Hai-Liang Li, Mingsheng Huang et al. · Signal Transduction and Targeted Therapy · 2023 · 283 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study

N. Lian, Hong Xie, Jinhua Huang et al. · Clinical Microbiology and Infection · 2020 · 239 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +6

Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging

Jie Peng, Shuai Kang, Zhengyuan Ning et al. · European Radiology · 2019 · 219 citations · Full text

Computing, Oncology, Surgery +17

Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study

Zhi‐Cheng Jin, Jian-Jia Chen, Xiaoli Zhu et al. · EClinicalMedicine · 2024 · 143 citations · Full text

Medicine, Oncology, Pharmacology +17

Camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and hepatic artery infusion chemotherapy for hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (TRIPLET): a phase II study

Tianqi Zhang, Zhijun Geng, Mengxuan Zuo et al. · Signal Transduction and Targeted Therapy · 2023 · 122 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +15